As an inhibitor of ASAH2, NC06 can reduce GSH synthesis and increase lipid ROS to activate ferroptosis in bone marrow mesenchymal stem cells and promote the activation of tumor‐infiltrating cytotoxic T lymphocyte (CTL) to inhibit tumor growth in vivo.78 Here, ASAH2 is linked to neoplasm.